Monday April 24, 2023 – Today, a delegation from Diaverum led by the company’s CEO, Mr. Dimitris Moulavasilis met with Nipro’s President, Mr. Yoshihiko Sano, at the new Nipro Corporation Japan headquarters in Osaka, Japan, to mark the signing and official commencement of a prolonged partnership between the parties.
Nipro and Diaverum are committed to further strengthening ties and exploring long-term opportunities for continued and diversified collaboration in many areas, reinforcing Nipro’s role as a strategic partner of Diaverum. The concept of “Value-Based-Care” resonates with both companies, who share the ultimate goal of delivering the best possible patient outcomes by providing efficient, holistic, and adequate treatment solutions.
About Nipro:
Nipro Medical Europe is part of Nipro Corporation Japan, a leading global healthcare company established in 1954. With over 35,000 employees worldwide, Nipro serves the Medical Device, Pharmaceutical, and Pharmaceutical Packaging industries.
About Diaverum:
Diaverum is a Swedish-born, multinational healthcare organization that provides life-enhancing renal care to patients with Chronic Kidney Disease (CKD), empowering them to live fulfilling lives. As a global leader and the largest independent renal service provider in Europe, it cares for around 39,000 patients across 440 clinics in 23 countries globally.
